Pulmonx Corporation (NASDAQ: LUNG) reported Q2 EPS of ($0.38), $0.02 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $23.86 million versus the consensus estimate of $23.47 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.